 |
 |

Neuromics
Roger N. Rosenberg, MD, Editor
Arch Neurol. 2008;65(3):304.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Our call for papers for this special theme issue resulted in a vigorous and robust response. In this issue and the April issue of Archives, clinical and molecular neurogenetics and neuromics—the genomic analyses of neurological disorders and functions—are represented by truly outstanding scientific presentations covering a wide array of subjects by world-class authorities in the field. We are most grateful for their support. The diversity of articles includes genome whole-array analyses for Alzheimer disease and multiple sclerosis, providing a neuromic perspective. Neurological review topics include gene-targeted therapies; retromer gene polymorphisms and Alzheimer disease; a HapMap analysis; stem cells and neurological disease; and defining the tau and progranulin mutations causing frontotemporal disease.
Original scientific contributions included in either the March or April issues cover interferon gamma polymorphisms and risk of multiple sclerosis; early-onset inherited Alzheimer disease due to Arctic amyloid precursor protein gene mutations; progranulin . . . [Full Text of this Article] AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|